Dep Doc, Dep Cab, Dep Irin & AZD, what a list! Additionally they plan to add 1-2 new Dep candidates each year. Their DEP technology is worth billions when / if it gets to market. the reduction in side effects alone is a company maker, improved efficacy and we are off to the races!
I know I am like a broken record on this, but get Dep Doc to complete phase II and the company will have a significant re-rate. It's proof of concept for the entire Dep portfolio. Licensing deals will flow and we can all put the last few months / years of 'extreme patience' behind us.
Ann: DEP irinotecan phase 2 commences after positive phase 1, page-10
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |